Z-2684-2020 Class II Terminated

Recalled by NuVasive Inc — San Diego, CA

FDA device recall Z-2684-2020 was initiated by NuVasive Inc on Jun 10, 2020 and is designated Class II. Reason for recall: The NVM5 EMG Module kit intended for intraoperative neurophysiologic monitoring during spinal surgery contains incorrect component, part number 1715945, SSEP harness instead of the the correct part… The recall status is terminated (terminated Mar 22, 2021). Affected quantity: 23.

Recall details

Product Type
Devices
Report Date
Jul 29, 2020
Initiation Date
Jun 10, 2020
Termination Date
Mar 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23

Product description

Nuvasive NVM5 EMG Module, REF 8020015, Rx ONLY, CE2797, Nonsterile, UDI: 00887517206633 - Product Usage: is intended for intraoperative neurophysiologic monitoring during spinal surgery.

Reason for recall

The NVM5 EMG Module kit intended for intraoperative neurophysiologic monitoring during spinal surgery contains incorrect component, part number 1715945, SSEP harness instead of the the correct part number 1747065, NVM5 Harness, Gen 3.5 EM. This issue can result in delay in therapy or lack of EMG neuromonitoring during surgery if the surgeon elects to proceed without the NVM5.

Distribution pattern

US Nationwide distribution including in the states of AR, CA, IA, IL, WI. OUS: None

Code information

Lot 1075097

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2684-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2684-2020. Report a data issue: hello@regdatalab.com.